Clinical effect of reduning combined with gamma globulin treatment on symptom improvement serum levels of IL-6, 25-(OH)D and LDH in children with severe mycoplasma pneumonia

Abstract

Objectives: To investigate the effects of Reduning combined with gamma globulin on symptom improvement and serum levels of interleukin-6 (IL-6), 25-hydroxyvitamin D[25-(OH)D] and lactate dehydrogenase (LDH) in children with severe mycoplasma pneumonia (MP).
 Methods: A total of 123 children with severe MP admitted to the Changzhou Cancer Hospital affiliated to Soochow University from May 2018 to April 2020 were selected as subjects and randomly divided into three groups: control Group-A, control Group-B and the observation group, with 41 cases in each group. Control Group-A was given with Reduning, control Group-B was treated with gamma globulin, while the observation group was treated with Reduning injection combined with gamma globulin. The clinical efficacy, symptom improvement, incidence of adverse reactions, serum levels of IL-6, 25-(OH)D, LDH, Toll-like receptor 4/myeloid differentiation factor 88 (TLR4/MyD88) signaling pathway and T lymphocyte subsets before and after treatment were statistically compared between the three groups.
 Results: The total effective rate of treatment in the observation group was higher than that in control Group-A and control Group-B (p<0.05); The time for body temperature, lung rales, and cough to return to normal in the observation group was shorter than that in control Group-A and control Group-B (p<0.05). After treatment, the observation group had lower serum levels of IL-6, LDH, and higher levels of 25-(OH)D compared with control Group-A and control Group-B (p<0.05). Moreover, the observation group had lower serum expressions of TLR4 and MyD88 (p<0.05), higher serum levels of CD4+, CD4+/CD8+, and lower CD8+ compared with control Group-A and control Group-B (p<0.05). No significant difference can be seen in the comparison of the incidence of adverse reactions between the three groups (p>0.05).
 Conclusions: Reduning combined with gamma globulin in the treatment of severe MP is worthy of clinical promotion and application. With such a treatment regimen, the immune function of children with severe MP can be significantly enhanced, the inflammatory response can be suppressed, and symptom improvement can be promoted, further improving the treatment outcome.
 doi: https://doi.org/10.12669/pjms.38.4.5203
 How to cite this:Ma X, Gao W, An J. Clinical effect of reduning combined with gamma globulin treatment on symptom improvement serum levels of IL-6, 25-(OH)D and LDH in children with severe mycoplasma pneumonia. Pak J Med Sci. 2022;38(4):---------. doi: https://doi.org/10.12669/pjms.38.4.5203
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Correlation between 25 (OH) D levels in aqueous humor and the patients with ARC

“…25 (OH) D is a neuroendocrine immune regulatory hormone that can regulate the balance of calcium and phosphorus, act on neutrophils, macrophages, and lymphocytes, and stimulate the expression of antimicrobial peptides, thereby affecting the body's inflammatory response and antimicrobial activity. 16 Research suggested that long-term 25 (OH) D deficiency could promote the occurrence of oxidative stress, leading to the occurrence of chronic inflammation. Adequate levels of 25 (OH) D inhibited the release of inflammatory cytokines such as interleukin-6 and tumor necrosis factor-α.…”

“…25 (OH) D is a neuroendocrine immune regulatory hormone that can regulate the balance of calcium and phosphorus, act on neutrophils, macrophages, and lymphocytes, and stimulate the expression of antimicrobial peptides, thereby affecting the body's inflammatory response and antimicrobial activity. 16…”

Effect of comprehensive nursing intervention on the efficacy of spleen aminopeptide combined with aerosol inhalation in the treatment of pediatric pneumonia

“…Despite major advances in its prevention and treatment, pneumonia remains the primary cause of death in children outside the neonatal period. 11 There are many risk factors leading to pediatric pneumonia, including age, malnutrition, immunosuppression, pathogenic microbial infection, etc., 12 , 13 among which pulmonary inflammation caused by pathogens such as viruses and bacteria is the most common. 14 Pediatric pneumonia is mainly manifested clinically as fever, cough, shortness of breath and dyspnea, wet rales on lung auscultation, and inflammatory lesions found on chest imaging examination.…”

Pneumonia in Children under five years old in KPK: Symptoms and presentation

“…The primary therapeutic approaches for pediatric pneumonia can be separated into etiological treatment and symptomatic treatment. The preferred approach for etiological treatment is antiviral vitamin therapy [24][25][26][27] .…”